Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Antilope Project Resource Report Resource Website 1+ mentions |
Antilope Project (RRID:SCR_003829) | Antilope | standard specification, portal, data or information resource, consortium, organization portal, narrative resource | Consortium focused on making electronic health data more interoperable, both within and outside of Europe, with the intention to create, validate, and disseminate standard methods to test and certify electronic health solutions and services. In particular it will: Drive the adoption of recognized sets of profiles and underlying standards for eHealth interoperability, and improve the impact of the EU and International eHealth standards development process; Define and validate testing guidelines and common approaches on Interoperability Labelling and Certification processes at European and at National / Regional level. Four work packages were created to provide guidelines, recommendations and frameworks based on a set of use cases, related profiles and standards, Interoperability Quality Management System, testing guidelines and Certification process. All the deliverables will be presented for validation and promotion by organizing workshops across Europe. | consortium, interoperability, electronic health data, data sharing, testing, certification, ehealth | is listed by: Consortia-pedia | European Union FP7 325077 | nlx_158143 | SCR_003829 | 2026-08-15 11:22:36 | 1 | ||||||||
|
Selleck Chemicals LLC Resource Report Resource Website 100+ mentions |
Selleck Chemicals LLC (RRID:SCR_003823) | commercial organization | An Antibody supplier | antibody, chemical supply, selleck chemicals | nlx_152457 | SCR_003823 | Selleck Chemicals | 2026-08-15 11:22:36 | 235 | ||||||||||
|
BioClinica Resource Report Resource Website 100+ mentions |
BioClinica (RRID:SCR_003789) | BioClinica | commercial organization | Pennsylvania-based company supporting pharmaceutical and medical device innovation with imaging core lab, EDC, IVR / IWR, CTMS, and supply chain forecasting and optimization. Its initial service was medical imaging for clinical trials. It is used to capture, collect, control quality, provide blinded reading services to the final delivery to the sponsor company and to the FDA or EMEA if required for medical images in a wide range of imaging modalities. (Wikipedia) | clinical trial, pharmaceutical, medical device, medical imaging, cardiac safety, clinical | Crossref funder ID: 100007742, ISNI: 0000 0004 0602 1531, Wikidata: Q4914605, grid.430790.9, nlx_158082 | https://ror.org/03t95yr58 | SCR_003789 | BioClinica Inc. | 2026-08-15 11:22:41 | 101 | ||||||||
|
Medical University of South Carolina; South Carolina; USA Resource Report Resource Website 1+ mentions |
Medical University of South Carolina; South Carolina; USA (RRID:SCR_003828) | MUSC | university | Public medical school in Charleston, South Carolina. Opened in 1824 as small private college aimed at training physicians. One of the oldest continually operating schools of medicine in the United States and the oldest in the Deep South. |
is affiliated with: NIH StrokeNet is related to: Clinical and Translational Science Awards Consortium is parent organization of: MUSC Health News is parent organization of: Hollings Cancer Center Tissue Biorepository and Research Pathology Services Shared Resource is parent organization of: SPARC Request is parent organization of: Medical University of South Carolina Department of Cell and Molecular Pharmacology and Experimental Therapeutics is parent organization of: Medical University of South Carolina Center on Aging is parent organization of: MUSC Health Podcast Library is parent organization of: Charleston Heart Study is parent organization of: Diffusional Kurtosis Estimator is parent organization of: ArrayQuest is parent organization of: MUSC DNA Microarray Database is parent organization of: NiiStat is parent organization of: MRIcroS is parent organization of: Medical University of South Carolina College of Dental Medicine Gnotobiotic Animal Core Facility is parent organization of: University of South Carolina Electron Microscopy Core Facility is parent organization of: Medical University of South Carolina Hollings Cancer Center Cell and Molecular Imaging Core Facility is parent organization of: Medical University of South Carolina MUSC Mouse Behavior Phenotyping Core Facility is parent organization of: Medical University of South Carolina AI High Performance Computing Core |
GRID grid.259828.c, , nlx_34109, Wikidata Q6806451, ISNI 0000 0001 2189 3475, Crossref Funder ID 100006942 | https://ror.org/012jban78 | SCR_003828 | Medical University of South Carolina | 2026-08-15 11:22:42 | 3 | ||||||||
|
AirPROM Resource Report Resource Website |
AirPROM (RRID:SCR_003827) | AirPROM | organization portal, data or information resource, consortium, portal | Consortium focused on developing computer and physical models of the airway system for patients with asthma and chronic obstructive pulmonary disease (COPD). Developing accurate models will better predict how asthma and COPD develop, since current methods can only assess the severity of disease. They aim to bridge the gaps in clinical management of airways-based disease by providing reliable models that predict disease progression and the response to treatment for each person with asthma or COPD. A data management platform provides a secure and sustainable infrastructure that semantically integrates the clinical, physiological, genetic, and experimental data produced with existing biomedical knowledge from allied consortia and public databases. This resource will be available for analysis and modeling, and will facilitate sharing, collaboration and publication within AirPROM and with the broader community. Currently the AirPROM knowledge portal is only accessible by AirPROM partners. | model, airway system, lung, consortium, clinical, imaging, respiratory system, tissue sample, airway model, genomic, gas diffusion mri, airway development, function, physiological, genetic, computational model, gene-environment interaction |
is listed by: Consortia-pedia has parent organization: European Lung Foundation |
European Union FP7 | nlx_158142 | SCR_003827 | Airway Disease Predicting Outcomes through Patient Specific Computational Modelling | 2026-08-15 11:22:38 | 0 | |||||||
|
Quretec Resource Report Resource Website 1+ mentions |
Quretec (RRID:SCR_003826) | Quretec | commercial organization | Commercial organization that builds software for collection, management, and analysis of complex data, most typical in biomedical domain. The solutions are generic and can be used for multitude of uses and application domains. | data capture, data management, analysis, biomedical | is related to: AgedBrainSYSBIO | grid.436973.c, Wikidata: Q30291134, nlx_158133 | https://ror.org/02ca38p84 | SCR_003826 | Quretec Ltd., Quretec Ltd | 2026-08-15 11:22:36 | 2 | |||||||
|
AgedBrainSYSBIO Resource Report Resource Website 1+ mentions |
AgedBrainSYSBIO (RRID:SCR_003825) | AgedBrainSYSBIO | organization portal, data or information resource, consortium, portal | Consortium focused on identifying the foundational pathways responsible for the aging of the brain, with a focus on Late Onset Alzheimer's disease. They aim to identify the interactions through which the aging phenotype develops in normal and in disease conditions; modeling novel pathways and their evolutionary properties to design experiments that identify druggable targets. As early steps of neurodegenerative disorders are expected to impact synapse function the project will focus in particular on pre- or postsynaptic protein networks. The concept is to identify subsets of pathways with two unique druggable hallmarks, the validation of interactions occurring locally in subregions of neurons and a human and/or primate accelerated evolutionary signature. The consortium will do this through six approaches: * identification of interacting protein networks from recent Late-Onset Alzheimer Disease-Genome Wide Association Studies (LOAD-GWAS) data, * experimental validation of interconnected networks working in subregion of a neuron (such as dendrites and dendritic spines), * inclusion of these experimentally validated networks in larger networks obtained from available databases to extend possible protein interactions, * identification of human and/or primate positive selection either in coding or in regulatory gene sequences, * manipulation of these human and/or primate accelerated evolutionary interacting proteins in human neurons derived from induced Pluripotent Stem Cells (iPSCs) * modeling predictions in drosophila and novel mouse transgenic models * validation of new druggable targets and markers as a proof-of-concept towards the prevention and cure of aging cognitive defects. The scientists will share results and know-how on Late-Onset Alzheimer Disease-Genome Wide Association Studies (LOAD-GWAS) gene discovery, comparative functional genomics in mouse and drosophila models, in mouse transgenic approaches, research on human induced pluripotent stem cells (hiPSC) and their differentiation in vitro and modeling pathways with emphasis on comparative and evolutionary aspects. The four European small to medium size enterprises (SMEs) involved will bring their complementary expertise and will ensure translation of project results to clinical application. | consortium, drug, drug development, brain, phenotype, presynaptic, protein network, postsynaptic, systems biology, synapse, neuron, protein interaction, network, induced pluripotent stem cell, pathway, genome wide association study, cognitive defect, gene, protein |
is listed by: Consortia-pedia is related to: Pasteur Institute of Lille; Lille; France is related to: Mouse Clinical Institute; Alsace; France is related to: Hybrigenics is related to: Inserm Transfert is related to: VIB; Flanders; Belgium is related to: Quretec is related to: Gene Bridges is related to: European Bioinformatics Institute is related to: Tel Aviv University; Ramat Aviv; Israel is related to: SIB Swiss Institute of Bioinformatics is related to: Babraham Institute has parent organization: National Institute of Health and Medical Research; Rennes; France has parent organization: Inserm Transfert |
European Union FP7 305299 | nlx_158132 | SCR_003825 | 2026-08-15 11:22:42 | 3 | ||||||||
|
Onyx Pharmaceuticals Resource Report Resource Website 1+ mentions |
Onyx Pharmaceuticals (RRID:SCR_003782) | Onyx, ONXX | commercial organization | November 2020, Onyx merged with Legacy Acquisition Corp. to form PARTS iD, Inc. Our data intelligence, integrated platforms, product cataloging, digital marketing expertise, and virtual warehousing have ensured our continued leadership in the competitive marketplace. | drug, pharmaceutical, biotechnology | nlx_158070 | https://www.biospace.com/employer/540942/onyx-pharmaceuticals-inc-/ | SCR_003782 | Onyx Pharmaceuticals Inc. | 2026-08-15 11:22:37 | 5 | ||||||||
|
Sciencewise Resource Report Resource Website |
Sciencewise (RRID:SCR_003780) | Sciencewise | knowledge environment | Sciencewise-ERC is the UK's national center for public dialogue in policy making involving science and technology issues. It provides co-funding and specialist advice and support to Government departments and agencies to develop and commission public dialogue activities in emerging areas of science and technology. It consists of a comprehensive online resource of information, advice and guidance together with a wide range of support services aimed at policy makers and all the different stakeholders involved in science and technology policy making, including the public. Sciencewise-ERC works with central Government and its agencies, and executive, advisory and non-departmental public bodies. Some of the Government departments include the Department for Environment, Food and Rural Affairs (Defra), the Department of Energy and Climate Change (DECC) and most recently HM Treasury. | public dialogue | Department for Business Innovation and Skills BIS UK Gov | nlx_143528 | SCR_003780 | Sciencewise - ERC, Sciencewise Expert Resource Center, Sciencewise Expert Resource Centre for Public Dialogue In Science and Innovation, Sciencewise Expert Resource Centre, Sciencewise-ERC | 2026-08-15 11:22:40 | 0 | ||||||||
|
European Federation of Pharmaceutical Industries and Associations Resource Report Resource Website 10+ mentions |
European Federation of Pharmaceutical Industries and Associations (RRID:SCR_003820) | EFPIA | institution | Federation representing the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, it is the voice on the EU scene of 1,900 companies committed to researching, developing and manufacturing new medical treatments. In addition, it is active in partnering in EU Research programmes, such as the IMI (Innovative Medicines Initiative), Europe's largest public-private partnerships. They also work on corporate social responsibility initiatives with others healthcare stakeholders, such as patient groups and healthcare professionals. EFPIA has specialized committees and task forces focused on key areas of activity. EFPIA also includes two specialized groups focusing on vaccines and biotechnology, respectively: * Vaccines Europe (formerly European Vaccine Manufacturers, EVM) produces approximately 80% of vaccines used worldwide * European Biopharmaceutical Enterprises (EBE) harness biotechnology to develop approximately one-fifth of new medicines | pharmaceutical, medicine, vaccine, biotechnology, manufacturing, corporate |
is affiliated with: Merck is affiliated with: Roche is related to: Innovative Medicines Initiative is parent organization of: Innovative Medicines Initiative |
nlx_158124, grid.484123.8, ISNI: 0000 0000 9246 8110, Wikidata: Q1376562 | https://ror.org/00g1x4v36 | SCR_003820 | 2026-08-15 11:22:36 | 20 | ||||||||
|
Avid Radiopharmaceuticals Resource Report Resource Website |
Avid Radiopharmaceuticals (RRID:SCR_003786) | commercial organization | Subsidiary of Eli Lilly and Company who develops new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies. The company has developed a radioactive tracer called florbetapir (18F). Florbetapir can be used to detect beta amyloid plaques in patients with memory problems using positron emission tomography (PET) scans, making the company the first to bring to market an FDA-approved method that can directly detect this hallmark pathology of Alzheimer's disease. | molecular imaging agent, beta amyloid plaque, pet | Alzheimer's disease | nlx_158076 | SCR_003786 | Avid Radiopharmaceuticals Inc. | 2026-08-15 11:22:41 | 0 | |||||||||
|
BioSHaRE Resource Report Resource Website 10+ mentions |
BioSHaRE (RRID:SCR_003811) | BIOSHARE-EU | standard specification, portal, data or information resource, consortium, organization portal, narrative resource | A consortium of leading biobanks and international researchers from all domains of biobanking science to ensure the development of harmonized measures and standardized computing infrastructures enabling the effective pooling of data and key measures of life-style, social circumstances and environment, as well as critical sub-components of the phenotypes associated with common complex diseases. The overall aim is to build upon tools and methods available to achieve solutions for researchers to use pooled data from different cohort and biobank studies. This, in order to obtain the very large sample sizes needed to investigate current questions in multifactorial diseases, notably on gene-environment interactions. This aim will be achieved through the development of harmonization and standardization tools, implementation of these tools and demonstration of their applicability. BioSHaRE researchers are collaborating with P3G, the Global Alliance for Genomics and Health, IRDiRC (International Rare Diseases Research Consortium), H3Africa and other organizations on the development of an International Code of Conduct for Genomic and Health-Related Data Sharing. A draft version is available for external review. Generic documents have been prepared covering areas of biobanking that are of major importance. SOPs have been finalized for blood withdrawal (SOPWP5001blood withdrawal), manual blood processing (SOPWP5002blood processing), shipping of biosamples (SOPWP5003shipping) and withdrawal, processing and storage of urine samples (SOPWP5004urine). | gene-environment interaction, life-style, social circumstance, environment, phenotype, disease, biobank, socio-economic factor, data sharing, gene, clinical |
is listed by: Consortia-pedia has parent organization: University of Groningen; Groningen; Netherlands is parent organization of: BioResource Impact Factor |
European Union FP7 | nlx_158110 | SCR_003811 | Biobank Standardisation and Harmonisation for Research Excellence, Biobank Standardisation and Harmonisation for Research Excellence in the European Union | 2026-08-15 11:22:36 | 22 | |||||||
|
MIAPA Resource Report Resource Website 1+ mentions |
MIAPA (RRID:SCR_003777) | MIAPA | data or information resource, narrative resource, standard specification | Central hub for resources related to developing and deploying a Minimal Information for a Phylogenetic Analysis (MIAPA) standard. | phylogeny, dna, amino acid sequence |
is listed by: Minimum Information for Biological and Biomedical Investigations is listed by: GitHub is listed by: SourceForge |
PMID:16901231 | nlx_158100 | https://github.com/miapa/miapa/blob/master/checklist/MIAPA-checklist.md, http://mibbi.sourceforge.net/projects/MIAPA.shtml | SCR_003777 | Minimal Information for a Phylogenetic Analysis | 2026-08-15 11:22:35 | 1 | ||||||
|
Asthma UK Resource Report Resource Website 10+ mentions |
Asthma UK (RRID:SCR_003815) | Asthma UK | institution | Charity that aims to significantly reduce the number of asthma deaths, hospitalizations and living lives compromised by asthma helping over five million people with asthma in the UK through research, campaigning, health promotion and engagement with the asthma community. Asthma UK is a significant investor in asthma research within the UK and to date has invested over 50 million pounds into research for better treatments and ultimately a cure for asthma. | lung, treatment | is parent organization of: EARIP | Asthma | Crossref funder ID: 501100000362, ISNI: 0000 0000 9981 854X, nlx_158172, grid.453156.0 | https://ror.org/03z7xev21 | SCR_003815 | 2026-08-15 11:22:41 | 13 | |||||||
|
EURORDIS Resource Report Resource Website 10+ mentions |
EURORDIS (RRID:SCR_003814) | EURORDIS | nonprofit organization | EURORDIS is a non-governmental patient-driven alliance of patient organizations and individuals active in the field of rare diseases, dedicated to improving the quality of life of all people living with rare diseases in Europe. It is a not-for-profit organization and represents more than 479 rare disease organizations in 45 different countries (of which 25 are EU Member States), covering more than 4,000 rare diseases. It is therefore the voice of the 30 million patients affected by rare diseases throughout Europe. EURORDIS aims at improving the quality of life of people living with rare diseases in Europe through advocacy at the European level, support for research and drug development, networking patient groups, raising awareness and other actions designed to fight against the impact of rare diseases on the lives of patients and family. EURORDIS' training programs and resources are designed to strengthen the capacity of rare disease patients' representatives. Training empowers patients' representatives to advocate effectively for rare diseases at both the local and EU level. Key issues affecting patients of Rare Diseases on which we actively work: * Sustaining rare diseases as an EU public health priority * Making Rare Diseases A Public Health Priority In All Member States * Rare Diseases: An International Public Health Priority * Improving Access To Orphan Drugs * Improving Access To Quality Care * Promoting cross-border healthcare and patient mobility * Bridging Patients And Research * Genetic testing and newborn screening | French Muscular Dystrophy Association ; European Union ; members ; corporate foundations ; health industry |
Wikidata: Q5412882, grid.433753.5, nlx_143535 | https://ror.org/019w4mg02 | SCR_003814 | EURORDIS - Rare Diseases Europe | 2026-08-15 11:22:38 | 40 | ||||||||
|
COMPACT Resource Report Resource Website 50+ mentions |
COMPACT (RRID:SCR_003850) | COMPACT | organization portal, data or information resource, consortium, portal | Consortium to reduce delivery and targeting bottlenecks for developing novel innovative biopharmaceutical based medicines. The project aims to shed new light on the obstacles biopharmaceuticals (medicines based on biological molecules such as proteins, peptides or nucleic acids) need to overcome to get to where they are needed in the body. The team will then use this information to develop and validate biopharmaceutical formulations to deliver these novel drugs to their targets. By finding more effective ways of administering these biopharmaceutical drugs, and improving their ability to travel through the body to where they are needed, COMPACT will allow more patients to benefit from biopharmaceuticals. Furthermore, designing less invasive administration routes and reducing the dose (and therefore the side effects) and frequency of administration will help to improve patient compliance with treatments. | drug, biopharmaceutical, drug delivery, drug target, drug development |
is listed by: Consortia-pedia has parent organization: Utrecht University; Utrecht; Netherlands |
Innovative Medicines Initiative ; EFPIA |
nlx_158164 | SCR_003850 | Collaboration on the optimisation of macromolecular pharmaceutical access to cellular targets, Collaboration on the Optimization of Macromolecular Pharmaceutical Access to Cellular Targets | 2026-08-15 11:22:36 | 57 | |||||||
|
Canadian Consortium on Neurodegeneration in Aging Resource Report Resource Website |
Canadian Consortium on Neurodegeneration in Aging (RRID:SCR_003846) | CCNA | organization portal, data or information resource, consortium, portal | Consortium that will be the premier research hub for all aspects of research involving neurodegenerative diseases that affect cognition in aging - including Alzheimer's disease. They will promote high impact, inter-institutional and interdisciplinary collaboration through a pan-Canadian approach, and will position Canadian researchers to lead and participate in a new wave of national and international initiatives with congruent goals. The consortium focuses research into the basic mechanisms of neurodegenerative diseases, accelerating the development of tools that can be used to assist in the diagnosis and treatment of the diseases. The intended outcome of these tools is to improve the quality of life and services patients with neurodegenerative diseases. As part of the Canadian contribution to the International Collaborative Research Strategy for Alzheimer's disease, the consortium brings together Canadian government agencies (federal and provincial), foundations, pharmaceutical companies, philanthropists and international stakeholders to identify if there are common causes and risk factors to neurodegenerative diseases. The consortium is focused on three themes: * Primary Prevention aimed at preventing the disease from developing * Secondary Prevention focused on delaying the clinical manifestations of the already developing disease * Quality of Life designed for helping individuals, caregivers and the health system in the context of a clinically developed disease. | cognition, biomarker, primary prevention, secondary prevention, quality of life, clinical, late adult human, prevention |
is listed by: Consortia-pedia has parent organization: Institute of Aging - CIHR |
Canadian Institutes of Health Research ; Alzheimer Society of Canada ; Alzheimers Research UK |
nlx_158160 | SCR_003846 | Canadian Consortium on Neurodegeneration in Aging (CCNA) | 2026-08-15 11:22:42 | 0 | |||||||
|
Alzheimer's Research UK Resource Report Resource Website 10+ mentions |
Alzheimer's Research UK (RRID:SCR_003847) | ARUK | nonprofit organization | The UK's leading dementia research charity that funds world-class, pioneering scientists at leading universities to find preventions, treatments and a cure for dementia. | late adult human, treat, prevent, alzheimer, dementia, portal, funding resource | Alzheimer's disease, Dementia | ISNI: 0000 0000 9689 1581, Crossref funder ID: 501100002283, Wikidata: Q2840694, nlx_158161, grid.453466.6 | https://ror.org/02ymzm013 | SCR_003847 | Alzheimers Research UK | 2026-08-15 11:22:36 | 19 | |||||||
|
BiomarCaRE Resource Report Resource Website 10+ mentions |
BiomarCaRE (RRID:SCR_003841) | BIOMARCARE, BiomarCaRE | organization portal, data or information resource, consortium, portal | EU funded consortium including over 30 partner from academia and industry. BiomarCaRE aims to determine the value of established and emerging biomarkers to improve risk estimation of cardiovascular disease in Europe. BiomarCaRE relies on an exceptional resource of large scale epidemiological cohorts with long term follow-up and available bio specimens based on the population of the MORGAM Project as well as several cardiovascular disease cohorts and clinical trials. | drug, biomarker, diagnostic, cardiovascular risk, phenotype, ultrasound, mri, clinical, epidemiological, risk prediction, lifestyle, risk factor, heart | is listed by: Consortia-pedia | European Union FP7 | nlx_158154, SCR_013677 | SCR_003841 | BiomarCaRE.EU, Biomarker for Cardiovascular Risk Assessment in Europe (BIOMARCARE), Biomarker for Cardiovascular Risk Assessment in Europe | 2026-08-15 11:22:39 | 28 | |||||||
|
BetaBat Resource Report Resource Website 1+ mentions |
BetaBat (RRID:SCR_003834) | BetaBat | organization portal, data or information resource, consortium, portal | Project that aims to develop new treatment strategies based on knowledge of cellular dysfunction in diabetes. They will perform a detailed organelle diagnosis based on both focused and systems biology approaches, which will provide the scientific rationale for the design of specific interventions to boost the capacity of beta cells and brown adipocytes to regain homeostatic control. They propose that only by understanding the complex molecular mechanisms triggering cellular dysfunction in diabetes, and by integrating this knowledge at the systems level, will it be possible to develop interventional therapies that protect and restore beta cell and (Brown adipose tissue) BAT function. The ultimate goal is to offer individual therapeutic choices based on both genetic information and organelle diagnosis. | cellular dysfunction, beta cell, brown adipose tissue, organelle, genetic, drug, drug development, pancreas |
is listed by: Consortia-pedia has parent organization: Free University of Brussels; Brussels; Belgium |
European Union FP7 | nlx_158149 | SCR_003834 | BetaBat - Development of novel treatment strategies based on knowledge of cellular dysfunction in diabetes, Development of novel treatment strategies based on knowledge of cellular dysfunction in diabetes, Development of novel treatment strategies based on knowledge of cellular dysfunction in diabetes (BetaBat) | 2026-08-15 11:22:42 | 1 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
